Thursday, 28 July 2016

Top 14 stocks in focus: Sun Pharma, Bharti Airtel, PNB

Check out the companies which will be in focus during trade today based on recent and latest news developments.

Stock MarketSun Pharma: Sun Pharma and its wholly owned subsidiary and Almirall announced a licensing agreement on the development and commercialization of tildrakizumab for psoriasis in Europe.

Bharti Airtel: The company reported its net profit rose 70.9% to Rs.756.20 crore in the quarter ended June 2016 as against Rs.442.40 crore during the previous quarter ended June 2015. 

PNB: The bank will announce its Q1 numbers today.

Maruti Suzuki: The country’s largest passenger vehicle maker Maruti Suzuki India Limited announced that it will start sales of its first Light Commercial Vehicle (LCV) - Super Carry towards the end of August. 

State Bank of Bikaner and Jaipur: Reserve Bank of India has imposed an aggregate penalty of Rs. 20 million on the Bank in exercise of the powers conferred under Section 47(A)(1)(c) read with Section 46(4)(i) of the Banking Regulation Act, 1949 in case of advance import remittance irregularities.

Bharat Forge: Bharat Forge Limited and Elbit now hold 51% and 49% equity share capital of BF Elbit Advanced Systems Private Limited, respectively.

Dabur India: The company reported 11.8% rise in net profit at Rs.292.80 crore for the quarter ended June 30, 2016 against Rs.261.84 crore in the corresponding quarter a year ago.

Asian Paints: The company has posted a net profit after tax of Rs.5011.80 million for the quarter ended June 30, 2016 as compared to Rs. 4275.40 million for the quarter ended June 30, 2015.

Castrol India: The company has posted a net profit after tax of Rs.2069 million for the quarter ended June 30, 2016 as compared to Rs.1845 million for the quarter ended June 30, 2015.

RPG Life Sciences: Sun Pharmaceutical Industries signed an agreement with RPG Life Sciences Ltd to divest seven prescription brands in India.

Lupin: Lupin Pharmaceuticals Inc. has received tentative approval from the United States Food and Drug Administration (FDA) to market a generic equivalent of ViiV Healthcare’s (ViiV) Lexiva Tablets, 700 mg (Fosamprenavir Calcium Tablets, 700 mg). 

United Spirits: United Spirits said it will stop manufacturing operations in Bihar due to the ban on sale of alcohol in the state that took effect from 1 April.

L&T Infotech: L&T Infotech will announce its Q1 result today. The company announced a strategic partnership with GE Digital combining LTI’s diverse industrial capabilities with GE’s Predix cloud-based operating system for the Industrial Internet.

Glenmark: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Potassium Chloride Extended-Release Tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg), the generic version of K-Dur (Potassium Chloride) Extended-Release Tablets, 10 and 20 mEq, of Merck Sharp and Dohme Corp (which is no longer being marketed in the United States).

No comments:

Post a Comment